iBio Inc’s recently made public that its Chief Financial Officer Duran Felipe acquired Company’s shares for reported $25000.0 on Jan 10 ’25. In the deal valued at $2.72 per share,9,191 shares were bought. As a result of this transaction, Duran Felipe now holds 11,139 shares worth roughly $9022.59.
Then, Brenner Martin bought 9,191 shares, generating $25,000 in total proceeds. Upon buying the shares at $2.72, the insider now owns 18,316 shares.
Before that, Banjak Marc bought 9,191 shares. iBio Inc shares valued at $25,000 were divested by the Chief Legal Officer at a price of $2.72 per share. As a result of the transaction, Banjak Marc now holds 11,066 shares, worth roughly $8963.460000000001.
Chardan Capital Markets initiated its iBio Inc [IBIO] rating to a Buy in a research note published on May 28, 2024; the price target was $5. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in late November with a ‘”a Mkt outperform”‘ rating. Cantor Fitzgerald began covering IBIO with “an Overweight” recommendation on January 22, 2021. Alliance Global Partners started covering the stock on June 26, 2020. It rated IBIO as “a Buy”.
Price Performance Review of IBIO
On Tuesday, iBio Inc [NASDAQ:IBIO] saw its stock fall -6.77% to $0.81. Over the last five days, the stock has lost -14.23%. iBio Inc shares have fallen nearly -66.74% since the year began. Nevertheless, the stocks have fallen -68.30% over the past one year. While a 52-week high of $6.89 was reached on 03/03/25, a 52-week low of $0.64 was recorded on 04/22/25.
Levels Of Support And Resistance For IBIO Stock
The 24-hour chart illustrates a support level at 0.7841, which if violated will result in even more drops to 0.7533. On the upside, there is a resistance level at 0.8728. A further resistance level may holdings at 0.9307.
